CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Oxycodone HCI / naloxone HCI

Last Updated: July 5, 2011
Result type: Reports
Project Number: S0241
Product Line: Reimbursement Review

Generic Name: Oxycodone HCI / naloxone HCI

Brand Name: Targin

Manufacturer: Purdue Pharma

Indications: Pain, Moderate to severe and relief of opioid-induced constipation

Submission Type: Resubmission

Project Status: Complete

Date Recommendation Issued: January 25, 2012

Recommendation Type: Do not list